This patent teaches how to expand populations of islet cells in vitro for possible in vivo use in the treatment of type 1 diabetes. This technology seems very exciting, however the patent has some priority claims more than a decade ago and to our knowledge this therapy has yet to be clinically implimented.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.